Overview

Study on the Safety of Risperidone on Obese or Overweight Patients With Schizophrenia

Status:
Terminated
Trial end date:
2003-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety of risperidone treatment in patients who are overweight and/or obese.
Details
Lead Sponsor:
Janssen-Cilag, S.A.
Treatments:
Risperidone